BAILLIE GIFFORD & CO 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 10:49 am Sale |
2023-12-29 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BAILLIE GIFFORD & CO | 24,179,504 11.610% |
-641,346 (-2.58%) |
Filing |
| 2023-01-24 07:35 am Purchase |
2022-12-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BAILLIE GIFFORD & CO | 24,820,850 13.660% |
2,697,695 (+12.19%) |
Filing |
| 2022-01-27 10:18 am Purchase |
2021-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BAILLIE GIFFORD & CO | 22,123,155 13.870% |
5,104,498 (+29.99%) |
Filing |
| 2021-05-06 12:01 pm Purchase |
2021-04-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
BAILLIE GIFFORD & CO | 17,018,657 10.890% |
17,018,657 (New Position) |
Filing |